ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,317.59
-0.26%
Dow Jones
39,069.59
0.01%
Gold vs US Dollar
2,334.20
0.00%
Brent Oil
81.965
0.00%
Bitcoin
69,068.93
0.79%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Ophthotech Corp. (OPHT)

  7. Ophthotech Corp. (OPHT) News

OPHTHOTECH CORP. (OPHT)

Ophthotech Corp.
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OPHT
DateTimeSourceHeadlineSymbolCompany
18/04/201911:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OPHTOphthotech Corp.
16/04/201921:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPHTOphthotech Corp.
16/04/201912:30Business WireOphthotech Transitions to a Gene Therapy Focused Company Developing Treatments for Orphan Inherited Retinal Diseases & Change...NASDAQ:OPHTOphthotech Corp.
11/04/201921:52Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPHTOphthotech Corp.
11/04/201921:05Business WireOphthotech Obtains Exclusive Global License to AAV Gene Therapy Program for BEST1 Related Retinal DiseasesNASDAQ:OPHTOphthotech Corp.
03/04/201923:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPHTOphthotech Corp.
14/03/201912:00Business WireOphthotech to Present at the Alliance for Regenerative Medicine’s (ARM) 7th Annual Cell & Gene Therapy Investor DayNASDAQ:OPHTOphthotech Corp.
06/03/201913:00Business WireOphthotech to Present at the Cowen and Company 39th Annual Health Care ConferenceNASDAQ:OPHTOphthotech Corp.
01/03/201911:30Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:OPHTOphthotech Corp.
28/02/201922:38Edgar (US Regulatory)Annual Report (10-k)NASDAQ:OPHTOphthotech Corp.
28/02/201922:37Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:OPHTOphthotech Corp.
26/02/201912:20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPHTOphthotech Corp.
26/02/201912:15Business WireOphthotech Reports Fourth Quarter and Full Year 2018 Financial and Operating ResultsNASDAQ:OPHTOphthotech Corp.
19/02/201913:00Business WireOphthotech Corp. to Report Fourth Quarter & Full Year 2018 Financial Results & Host Conference Call on Tuesday, February 26, ...NASDAQ:OPHTOphthotech Corp.
14/02/201921:26Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OPHTOphthotech Corp.
14/02/201919:38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OPHTOphthotech Corp.
13/02/201921:47Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OPHTOphthotech Corp.
13/02/201911:08Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OPHTOphthotech Corp.
06/02/201916:53Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OPHTOphthotech Corp.
16/01/201919:30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPHTOphthotech Corp.
07/01/201913:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPHTOphthotech Corp.
07/01/201912:56Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPHTOphthotech Corp.
04/01/201923:39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPHTOphthotech Corp.
04/01/201923:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPHTOphthotech Corp.
03/01/201922:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPHTOphthotech Corp.
03/01/201922:37Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OPHTOphthotech Corp.
03/01/201913:00Business WireOphthotech Corporation to Present at the 37th Annual J.P. Morgan Healthcare ConferenceNASDAQ:OPHTOphthotech Corp.
02/01/201913:00Business WireOphthotech Announces the Addition of Ophthalmic Industry Leader, Calvin (Cal) W. Roberts, M.D., to Its Board of DirectorsNASDAQ:OPHTOphthotech Corp.
14/12/201822:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPHTOphthotech Corp.
14/12/201822:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPHTOphthotech Corp.
 Showing the most relevant articles for your search:NASDAQ:OPHT

Your Recent History

LSE
NG.
National Grid
LSE
SRSP
Sirius Petroleum
LSE
POS
Plexus
LSE
VAST
Vast Resources
LSE
BIRD
Blackbird
LSE
ENET
Ethernity Networks
LSE
CUSN
Cornish Metals
LSE
SCLP
Scancell
LSE
AVCT
Avacta
LSE
LLOY
Lloyds Banking
LSE
CHLL
Chill Brands
LSE
ZED
Zenova
LSE
BOO
Boohoo
LSE
GGP
Greatland Gold
LSE
SAR
Sareum
LSE
CLDN
Caledonia Investments
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved